No Data
No Data
China Red Medical (300981): Improvement of supply and demand relationship in the medical glove industry, company performance is expected to reach a turning point.
Event: The company released its 2023 annual report, achieving revenue of RMB 2.105 billion (+33.87%) and net income attributable to shareholders of the listed company of -RMB 131 million, and non-recurring items attributable to shareholders of the listed company
Express News | The ban on restricted shares with a market capitalization of 23.611 billion yuan was lifted today
Zhonghong Healthcare (300981.SZ) announced its 2023 annual results, with a net loss of 131 million yuan, a year-on-year profit to loss
Zhonghong Healthcare (300981.SZ) released the 2023 annual results report. The company achieved operating income during the reporting period...
Zhonghong Healthcare (300981.SZ): First repurchase of 290,000 shares on March 15
Gelonghui, March 18, 丨 Zhonghui Healthcare (300981.SZ) announced that on March 15, 2024, the company implemented the first repurchase through a dedicated securities account. The number of shares repurchased was 290,000 shares, accounting for 0.0744% of the company's total share capital (not excluding the number of shares in the previous repurchased special account). The maximum transaction price was 11.78 yuan/share, and the minimum transaction price was 11.67 yuan/share. The total amount paid was RMB 340.0826 million (excluding transaction fees).
Express News | More than 30 listed companies disclosed repurchase plans after the market and announced that 4 listed companies including Liangwei plan to repurchase for cancellation
Zhonghong Healthcare (300981.SZ): Plans to spend 6.658.05 million yuan to repurchase shares
Gelonghui, Feb. 27丨Zhonghui Healthcare (300981.SZ) announced that from January 12, 2024 to February 8, 2024, the closing price of Zhonghong Pulin Medical Products Co., Ltd. (“Company”) stock closing price has fallen below 15.1,519 yuan/share for 20 consecutive trading days. According to the company's “Plan to stabilize the company's stock price within three years after stock listing”, the conditions for triggering measures to stabilize stock prices have been met. In order to fulfill the promise of stable stock prices, and based on judgment of the company's value and confidence in future development, it is planned to use its own capital to concentrate on competition, taking into account factors such as the company's business situation and financial situation
No Data